Could not find what you are looking for?
Theranostics Program
Apollo Cancer Centres' Theranostics program combines diagnostic precision with therapeutic effectiveness using radioactive isotopes. Theranostics is a cutting-edge approach in personalized medicine that combines therapy and diagnostics to deliver highly targeted treatment for diseases, particularly cancer. The term is a blend of “therapeutics” and “diagnostics,” emphasizing its dual purpose: diagnosing the disease and treating it simultaneously or in a closely integrated manner.
How Theranostics Works
• Specific biomarkers or receptors present on disease cells are identified (e.g., proteins or genetic markers)
• A diagnostic agent, typically a radiopharmaceutical or a molecular probe, binds to the disease-specific target, allowing imaging via techniques such as PET or SPECT scans.
• A therapeutic agent, often linked to the same targeting molecule as the diagnostic agent, delivers localized treatment to the disease site.
• Imaging can also monitor treatment response, enabling adjustments to therapy if needed.
• Used in cancers like prostate and breast cancers
Our medical oncology team employs a comprehensive approach to determine the most appropriate treatment or combination of treatments for each patient, considering:
- Cancer type and stage
- Genetic profile
- Previous treatment history
- Overall health status
- Quality of life goals
